Last updated 2026-07-20
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$4.5M
total disclosed, rounds participated
Stages
—
About
Yuval Yanai is an experienced Israeli professional who serves as a director and chairman of audit, finance, and compensation committees in multiple public and private companies, primarily in the medical and life sciences industries. He has a significant background as a Chief Financial Officer for several notable Israeli companies, including Given Imaging Ltd., Koor Industries Ltd., Nice Systems Ltd., and Elscint Ltd. [2, 3, 4, 5]. He holds a B.A. in accounting and finance from Tel-Aviv University, Israel. [2, 3]
Portfolio · 1
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Yuval Yanai's primary investment focus by sector?
- Yuval Yanai has invested in the Health Tech & Life Sciences sector, with Efranat Pharma as a notable portfolio company.
- Which funding stage does Yuval Yanai typically invest in?
- Yuval Yanai has participated in Seed stage funding rounds.
- Can you name a key portfolio company for Yuval Yanai?
- Efranat Pharma, an anticancer immunotherapy treatment company, is a key portfolio company for Yuval Yanai.
- When did Yuval Yanai make their most recent recorded investment?
- Yuval Yanai's most recent recorded investment was in November 2014.
- What is the total amount raised by a portfolio company Yuval Yanai has invested in?
- Efranat Pharma, a portfolio company of Yuval Yanai, has raised $4.5M.
- What is Yuval Yanai's investment range?
- Yuval Yanai's investment range is $4.5M - $4.5M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 2 |
|---|